Nuformix (NFX)

Sector:

Pharma and Biotech

7.05p
   
  • Change Today:
    -0.15p
  • 52 Week High: 13.75
  • 52 Week Low: 1.95
  • Currency: UK Pounds
  • Shares Issued: 469.72m
  • Volume: 745,306
  • Market Cap: 33.12m
  • RiskGrade: 634
  • Beta: 0.08

Nuformix Overview

Nuformix is in the pharma and biotech sector and is currently trading at 7.05p per share. In the last year Nuformix's share price has ranged from 1.95p to 13.75p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -296.7% n/a
ROCE 431.0%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 55.4 n/a
Pr/Book 8.9  
Latest F'cast
Revenue 6000.0% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Nuformix Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-16 n/a (0.35) (0.58)p n/a n/a n/a n/a 0.0%
31-Mar-17 n/a (0.36) (0.10)p n/a n/a n/a n/a 0.0%
31-Mar-18 0.01 (1.97) (0.49)p n/a n/a n/a n/a 0.0%
31-Mar-19 0.61 (1.84) (0.36)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Nuformix Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-20 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Nuformix Company Announcements

Second Price Monitoring Extn 25-Nov-2019 16:41 RNS
Price Monitoring Extension 25-Nov-2019 16:36 RNS
Update and Placing Announcement 25-Nov-2019 07:00 RNS

Latest Nuformix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Nuformix Market Data

Currency UK Pounds
Share Price 7.05p
Change Today -0.15p
% Change -2.08 %
52 Week High 13.75
52 Week Low 1.95
Volume 745,306
Shares Issued 469.72m
Market Cap 33.12m
Beta 0.08
RiskGrade 634

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.89% below the market average43.89% below the market average43.89% below the market average43.89% below the market average43.89% below the market average
25.42% below the sector average25.42% below the sector average25.42% below the sector average25.42% below the sector average25.42% below the sector average
Price Trend
53.13% above the market average53.13% above the market average53.13% above the market average53.13% above the market average53.13% above the market average
62.71% above the sector average62.71% above the sector average62.71% above the sector average62.71% above the sector average62.71% above the sector average
Income Not Available
Growth
23.77% above the market average23.77% above the market average23.77% above the market average23.77% above the market average23.77% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Nuformix Dividends

No dividends found

Trades for 09-Dec-2019

Time Volume / Share Price
10:56 500 @ 7.07p
10:42 4,454 @ 6.92p
10:41 23,432 @ 6.95p
10:21 20,000 @ 7.09p
10:10 43,943 @ 6.95p

Nuformix Key Personnel

CEO Pascal Hughes
CEO Daniel Gooding

Top of Page